Wintergreen Research's Oxygen Concentrator: Market Opportunities, Strategies, and Forecasts, 2005 to 2011 (market briefing) Over 200 in-depth interviews are conducted for each report with a broad range of key participants and ...more

Market Study September 2005

US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts One major finding that emerges from this analysis is the surprising absence of the majority of US ...more

Management Report September 2005

PharmaVitae 2005: Almirall Global and US Analysis This analysis examines the market position and future outlook for Almirall. ...more

Market Study August 2005

PharmaVitae 2005: Almirall Global Analysis This company analysis examines Almirall's market position and future outlook. ...more

Market Study August 2005

Major Milestones: Female Sexual Dysfunction Female sexual dysfunction affects an estimated 84 million women across the seven major pharmaceutical ...more

Market Study August 2005

Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns? Tysabri was voluntarily withdrawn from the multiple sclerosis market in February 2005 following two cases ...more

Market Study August 2005

PharmaVitae 2005: Altana Global and US Analysis This company analysis examines Altana's market position and future outlook. ...more

Market Study August 2005

PharmaVitae 2005: Altana Global Analysis This company analysis examines Altana's market position and future outlook. ...more

Market Study August 2005

Commercial Insight: Antibacterials - Pharma Strikes Antibac Rapid uptake of products focused on drug-resistant infections, such as Pfizer's Zyvox (linezolid), has ...more

Management Report August 2005

Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles Coronary heart disease is the most common cause of death in Europe and the US, at a rate of one in five. ...more

Management Report July 2005

Biotech And Pharmaceutical Spinouts: Maximize your assets' potential in a context of increasing earning pressures Biotechnology and pharmaceutical companies are increasing their focus on their intellectual property and ...more

Management Report July 2005

Biotech And Pharmaceutical Spinouts: Maximize your assets' potential in a context of increasing earning pressures Biotechnology and pharmaceutical companies are increasing their focus on their intellectual property and ...more

Market Study July 2005

PharmaVitae 2005: MedImmune Global Analysis This analysis examines the market position and future outlook for MedImmune. ...more

Market Study July 2005

Commercial Insight: Antidiabetics - Billion Dollar Drugs, Pipeline Dreams? The diabetes epidemic has contributed to the expansion of the antidiabetics market in the past few years, ...more

Management Report July 2005

Case Profile: Alcohol Retailing on the European Forecourt Despite the existence of some restrictions on the sale of alcohol on the European forecourt, there is no ...more

Market Study July 2005

Commercial Insight: ADHD - Strattera Will Reign Supreme When Branded Stimulants Slump With annual revenues of over $2.6 billion in 2004, and a compound annual growth rate of 36. ...more

Management Report July 2005